(Press-News.org) Could future opioid overdoses, fatalities and other harms of opioid addiction be prevented if hospital emergency departments made better use of effective medications for opioid addiction?
A team of University of Michigan researchers thinks so.
Led by Thuy Nguyen of U-M's School of Public Health, the researchers analyzed national Medicaid claims data of patients ages 12 to 64 treated at U.S. emergency departments for opioid overdoses in 2018. They focused on ED visits for opioid overdose and the rate of initiation of FDA-approved medications for opioid addiction, including buprenorphine, methadone and extended release naltrexone.
The researchers found that less than 20% of Medicaid patients were started on these medications at the time of emergency care or within 30 days of discharge, despite the fact that these medications can be lifesaving.
"There are nearly 2 million opioid-related visits to emergency departments in the U.S. each year," said Nguyen, an assistant professor of health management and policy. "The fact that less than 1 in 6 ED visits resulted in filling prescriptions of medications for opioid use disorder suggests that crucial opportunities to prevent opioid overdose deaths are being missed for Medicaid patients."
The research was funded by a $10,000 grant from the Institute for Healthcare Policy & Innovation's 2022 Policy Sprint Initiative, one of four projects selected for the potential to complete timely policy-relevant projects that inform system-level solutions to advance health equity.
The project was driven by a growing public health crisis that saw a record 81,000 Americans die from opioid overdose in 2021.
According to the study brief, "a variety of barriers contribute to low rates of treatment initiation, including an inadequate number of professionals offering treatment in the community, gaps in OUD medication training and resources for health providers, and effective referral systems for addiction care between EDs and outpatient treatment facilities."
The study also includes a breakdown of regions and states that are most and least likely to start treatment for opioid addiction after ED visits for opioid overdose. Eight states (Massachusetts, Rhode Island, Vermont, New Hampshire, Maine, Connecticut, Pennsylvania and Maryland) had initiation rates between 20%-34%—considerably higher than the average.
"This suggests that better performance is possible," Nguyen said. "Understanding why these states are performing better than others could inform policymakers' strategies to expand treatment access following ED visits for opioid overdose."
In addition to Nguyen, the research team included Kao-Ping Chua, U-M Department of Pediatrics; Yang "Amy" Jiao, Department of Health Management and Policy, U-M School of Public Health; Stephanie Lee and Pooja Lagisetty, U-M Medical School Division of General Medicine; Amy Bohnert, U-M Medical School Department of Anesthesiology; and Keith Kocher, U-M Medical School Department of Emergency.
Drs. Nguyen, Chua, Lagisetty, Bohnert and Kocher are also affiliated with U-M's Institute for Healthcare Policy & Innovation.
Study: Use of Medications for Opioid Use Disorder After Overdoses Among Medicaid Enrollees
END
Lifesaving addiction medications are rarely started following opioid overdose emergencies
2023-09-18
ELSE PRESS RELEASES FROM THIS DATE:
Disparities in flu vaccine uptake persist in people with kidney disease
2023-09-18
Among adults with chronic kidney disease (CKD) enrolled in the Chronic Renal Insufficiency Cohort (CRIC), young age, Black race, and low levels of education and income were associated with lower likelihood of getting an annual flu shot.
Identifying risk factors for not receiving a flu vaccine (“non-vaccination”) in people living with kidney disease, who are at risk of flu and its complications, could inform strategies for improving vaccine uptake. In this study published in the American Journal of Kidney Diseases (AJKD), researchers led by Junichi Ishigami examined whether demographic factors, social ...
A suit of armor for cancer-fighting cells
2023-09-18
In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves modifying patients’ T-cells to target cancer cells, resulting in remarkable success rates for previously intractable forms of cancer.
Six CAR T cell therapies have secured FDA approval, and several more are in the pipeline. However, these therapies come with severe and potentially lethal side effects, namely cytokine release syndrome (CRS) and neurotoxicity. These drawbacks manifest as a range of symptoms—from high fever and vomiting to multiple ...
Dana-Farber leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma
2023-09-18
EMBARGOED: September 18, 2023 4PM EST
CONTACT: Nicole Oliverio, nicole_oliverio@dfci.harvard.edu, 617-257-0454
Boston – An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that ...
New research highlights importance of equity in education
2023-09-18
A new study looks at the impact of learning environments on the academic success of racialized students. Compared to their peers, these students feel they have less control in their academic environment, less confidence and self-efficacy in their academic abilities, and weaker connections to other students and professors.
The University of Ottawa study underscores that higher education institutions must recognize and address the specific needs of their racialized student communities and create inclusive learning environments that better meet these needs. Failing to do so could affect the overall psychological well-being and academic performance ...
Cell therapy can reduce risk of death from COVID-19 by 60%, study shows
2023-09-18
The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.
Their findings are reported in an article published in the journal Frontiers in Immunology.
The review covers 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
Cell therapy has come into increasingly frequent use in recent years ...
The pace of climate-driven extinction is accelerating, a UArizona-led study shows
2023-09-18
Climate change is causing extinctions at an increasing rate, a new study by the University of Arizona researchers shows. They surveyed populations of the Yarrow's spiny lizard in 18 mountain ranges in southeastern Arizona and analyzed the rate of climate-related extinction over time.
"The magnitude of extinction we found over the past seven years was similar to that seen in other studies that spanned almost 70 years," said John J. Wiens, a professor in the Department of Ecology and Evolutionary Biology at UArizona, ...
Nuclear medicine treatment cures lethal form of ovarian cancer in preclinical setting
2023-09-18
Reston, VA—A new 225Ac-DOTA-based pre-targeted radioimmunotherapy (PRIT) system has been shown to cure a highly lethal form of advanced intraperitoneal ovarian cancer in a preclinical setting with minimal side effects. Targeting the HER2 protein, which is commonly expressed in ovarian cancer, the therapy (anti-HER2 225Ac-PRIT) is a potential treatment for the otherwise incurable disease. This research was published in the September issue of The Journal of Nuclear Medicine.
Epithelial ovarian cancer is the most lethal ovarian cancer and frequently presents as advanced-stage disease, ...
Gene links exercise endurance, cold tolerance, and cellular maintenance in flies
2023-09-18
EMBARGOED FOR RELEASE UNTIL September 18, 2023 at 3:00 PM U.S. Eastern time
As the days get shorter and chillier in the northern hemisphere, those who choose to work out in the mornings might find it harder to get up and running. A new study in PNAS identifies a protein that, when missing, makes exercising in the cold that much harder—that is, at least in fruit flies.
A team from University of Michigan Medical School and Wayne State University School of Medicine discovered the protein in flies, which they named Iditarod after the famous long distance dog sled across Alaska, while studying metabolism and the effect of stress on the body.
They were particularly ...
Eureka baby! Groundbreaking study uncovers origin of ‘conscious awareness’
2023-09-18
Living things act with purpose. But where does purpose come from? How do humans make sense of their relation to the world and realize their ability to effect change? These fundamental questions of agency – acting with purpose – have perplexed some of the greatest minds in history including Sir Isaac Newton, Charles Darwin, Erwin Schrödinger and Niels Bohr.
A Florida Atlantic University study reveals groundbreaking insight into the origins of agency using an unusual and largely untapped source – human babies. Since goal-directed action appears in the first months ...
Study finds human-driven mass extinction is eliminating entire branches of the tree of life
2023-09-18
The passenger pigeon. The Tasmanian tiger. The Baiji, or Yangtze river dolphin. These rank among the best-known recent victims of what many scientists have declared the sixth mass extinction, as human actions are wiping out vertebrate animal species hundreds of times faster than they would otherwise disappear.
Yet, a recent analysis from Stanford University and the National Autonomous University of Mexico, published this week in the Proceedings of the National Academy of Sciences, shows the crisis may run even deeper. Each of the three species above was also the ...